A fresh look at incontinentia pigmenti

Archives of Dermatology

Volumn 139, Issue 9, 2003, Pages 1206-1208

  Happle, Rudolf ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VASCULOTROPIN;

ALBERS SCHOENBERG DISEASE; APOPTOSIS; CELL CLONE; DNA DETERMINATION; EDITORIAL; EOSINOPHILIA; EXON; GENE DELETION; GENE MUTATION; HUMAN; HYPOHIDROTIC ECTODERMAL DYSPLASIA; INCONTINENTIA PIGMENTI; INFLAMMATORY CELL; LYMPHEDEMA; NEWBORN PERIOD; PRIORITY JOURNAL; X CHROMOSOME INACTIVATION;

CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCONTINENTIA PIGMENTI; INFANT; INFANT, NEWBORN; MALE;

EID: 0141484647     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.9.1206     Document Type: Editorial

References (24)

1. Lenz W. Zur Genetik der Incontinentia pigmenti. Ann Paediatr, 1961;196:149-165.
2. Smahi A, Courtois G, Vabres P, et al, for the International Incontinentia Pigmenti (IP) Consortium. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. Nature. 2000;405:466-472.
3. Berlin AL, Paller AS, Chan LS. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology. J Am Acad Dermatol. 2002;47:169-187.
4. Hadj-Rabia S, Froidevaux D, Bodak N, et al. Clinical study of 40 cases of incontinentia pigmenti. Arch Dermatol. 2003;139:1163-1170.
5. Landy SJ, Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet. 1993;30:53-59.
6. Carney RG. Incontinentia pigmenti: a world statistical analysis. Arch Dermatol. 1976;112:535-542.
7. Happle R, Mathiass HH, Macher E. Sex-linked chondrodysplasia punctata? Clin Genet. 1977;11:73-76.
8. Parrish JE, Scheuerle AE, Lewis RA, Levy ML, Nelson DL. Selection against mutant alleles in blood leukocytes is a consistent feature in incontinentia pigmenti type 2. Hum Mol Genet. 1996;5:1777-1783.
9. Scheuerle AE. Male cases of incontinentia pigmenti: case report and review. Am J Med Genet. 1998;77:201-218.
10. Happle R. Incontinentia pigmenti versus hypomelanosis of Ito: the whys and wherefores of a confusing issue. Am J Med Genet. 1998;79:64-65.
11. Barnes PJ, Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory disease. N Engl J Med. 1997;336:1066-1071.
12. Makris C, Godfrey VL, Krahn-Senftleben G, et al. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell. 2000;5:969-979.
13. Rudolph D, Yeh WC, Wakeham A, et al. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 2000;14:854-862.
14. Barnes CM. Incontinentia pigmenti: a report of a case with persistent activity into adult life. Cutis. 1978;22:621-624.
15. Harris A, Collins J, Vetrie D, Cole C, Bobrow M. X inactivation as a mechanism of selection against lethal alleles: further investigation of incontinentia pigmenti and X linked lymphoproliferative disease. J Med Genet. 1992;29:608-614.
16. Woffendin H, Jakins T, Jouet M, et al. X-inactivation and marker studies in three families with incontinentia pigmenti: implications for counselling and gene localisation. Clin Genet. 1999;55:55-60.
17. Pfau A, Landthaler M. Recurrent inflammation in incontinentia pigmenti of a seven-year-old child. Dermatology. 1995;191:161-163.
18. Bodak N, Hadj-Rabia S, Hamel-Teillac D, de Prost Y, Bodemer C. Late recurrence of inflammatory first-stage lesions in incontinentia pigmenti: an unusual phenomenon and a fascinating pathologic mechanism. Arch Dermatol. 2003;139:201-204.
19. Zonana J, Elder ME, Schneider LC, et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet. 2000;67:1555-1562.
20. Aradhya S, Courtois G, Rajkovic A, et al. Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma). Am J Hum Genet. 2001;68:765-771.
21. Kosaki K, Shimasaki N, Fukushima H, Hara M, Ogata T, Matsuo N. Female patient showing hypohidrotic ectodermal dysplasia and immunodeficiency (HED-ID). Am J Hum Genet. 2001;69:664-666.
22. Courtois G, Smahi A, Israel A. NEMO/IKKgamma: linking NF-kappaB to human disease. Trends Mol Med. 2001;7:427-430.
23. Döffinger R, Smahi A, Bessia C, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-γB signalling. Nat Genet. 2001;27:277-285.
24. Karkkainen MJ, Ferrell RE, Lawrence EC, et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet. 2000;25:153-159.